Hi tuts, what's your take on the 2007 ph2 efti flu trial in contrast to the ph2 covid trial?
Ann: Phase II study for eftilagimod alpha in COVID-19 advances, page-26
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.015(5.17%) |
Mkt cap ! $432.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $656.7K | 2.189M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 85587 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 126061 | 24 |
View Market Depth
| Last trade - 12.40pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |